Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases

Hepatitis C Virus NS3/NS4A, a serine protease complex, has been found to interact with many host proteins and cause various adverse effects on cellular function and immune response. For example, the cleavage of important immune factors by NS3/NS4A has been suggested as a mechanism for the hepatitis C virus to evade innate immunity. The spectrum of susceptible substrates for NS3/NS4A cleavage certainly includes important immune modulator kinases such as IKK alpha, IKK beta, IKK epsilon, and TBK1, as demonstrated in this paper. We show that the kinase activities of these four host kinases were transformed in unexpected ways by NS3/NS4A. Treatment with NS3/NS4A caused a significant reduction in the kinase activities of both IKK alpha and IKK beta, suggesting that HCV might use its NS3/NS4A protease activity to deactivate the NF-kappa B-associated innate immune responses. In contrast, the kinase activities of both IKK epsilon and TBK1 were enhanced after NS3/NS4A treatment, and more strikingly, the enhancement was more than 10-fold within 20 min of treatment. Our mass spectroscopic results suggested that the cleavage after Cys89 in the kinase domain of IKK epsilon by NS3/NS4A led to their higher kinase activities, and three potential mechanisms were discussed. The observed kinase activity enhancement might facilitate the activation of both IKK epsilon- and TBK1-dependent cellular antiviral pathways, likely contributing to spontaneous clearance of the virus and observed acute HCV infection. After longer than 20 min cleavage, both IKK epsilon- and TBK1 gradually lost their kinase activities and the relevant antiviral pathways were expected to be inactivated, facilitating the establishment of chronic HCV infection.

Automated summary

Hepatitis C virus NS3/NS4A protease complex interacts with host proteins, causing adverse effects on cellular function and immune response. The cleavage of immune factors by NS3/NS4A helps the virus evade innate immunity. NS3/NS4A treatment reduces the kinase activities of IKK alpha and IKK beta, deactivating NF-kappa B-associated innate immune responses. However, it enhances the kinase activities of IKK epsilon and TBK1, facilitating antiviral pathways. After longer cleavage, IKK epsilon and TBK1 gradually lose their kinase activities, leading to the establishment of chronic HCV infection.